ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 890

$1.17M Total Retail Price of All Prescriptions

Rank: 28 out of 890

559 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

36% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 16,340 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,093 665 S3 1 3
LISINOPRIL 734 445 2 4
GABAPENTIN 730 459 3 12
OMEPRAZOLE 692 498 4 8
FUROSEMIDE 660 479 5 7
SIMVASTATIN 492 366 6 5
METFORMIN HCL 456 316 7 6
POTASSIUM CHLORIDE 439 305 8 11
MELOXICAM 439 284 8 18
LEVOTHYROXINE SODIUM 417 354 10 2
METOPROLOL SUCCINATE 406 262 11 17
CLONIDINE HCL 397 258 12 35
AMLODIPINE BESYLATE 396 293 13 1
METOPROLOL TARTRATE 319 223 14 15
ZOLPIDEM TARTRATE 313 185 15 19
PRAVASTATIN SODIUM 306 195 16 10
GLIMEPIRIDE 305 261 17 27
CARVEDILOL 295 226 18 22
HYDROCHLOROTHIAZIDE 262 166 19 9
SERTRALINE HCL 254 179 20 26
ISOSORBIDE MONONITRATE ER 238 190 21 60
RANITIDINE HCL 237 159 22 49
NEXIUM 235 88 23 14
LANTUS 232 185 24 50
NIFEDIPINE ER 231 189 25 75
ESCITALOPRAM OXALATE 216 149 26 51
TAMSULOSIN HCL 214 183 27 32
FAMOTIDINE 212 154 28 90
FENOFIBRATE 200 130 29 74
ATORVASTATIN CALCIUM 199 129 30 13
RISPERIDONE 198 153 31 78
CLOPIDOGREL 193 139 32 28
DIGOXIN 177 158 33 65
AZITHROMYCIN 176 121 34 37
SINGULAIR 175 95 35 79
ATENOLOL 174 130 36 23
DONEPEZIL HCL 171 171 37 30
MECLIZINE HCL 160 146 38 97
PREDNISONE 159 127 39 47
CRESTOR 157 100 40 25
WARFARIN SODIUM 157 136 40 24
DIOVAN 155 114 42 33
AMITRIPTYLINE HCL 149 97 R 43 43
CILOSTAZOL 146 113 44 223
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 92 45 21
TRICOR 140 94 46 98
FLOVENT HFA 138 78 47 327
PLAVIX 132 103 48 42
NAMENDA 131 131 49 36
COMBIVENT 130 57 50 144
ROPINIROLE HCL 126 83 51 93
FLUTICASONE PROPIONATE 123 96 52 39
DIVALPROEX SODIUM ER 123 65 52 192
PROAIR HFA 119 55 54 55
CITALOPRAM HBR 118 91 55 20
JANUVIA 118 100 55 59
TRAMADOL HCL 112 60 57 16
LYRICA 109 68 58 71
MONTELUKAST SODIUM 107 50 59 130
PREMARIN 106 29 R 60 105
FINASTERIDE 105 92 61 108
QUETIAPINE FUMARATE 105 56 61 73
CYMBALTA 101 59 63 45
HUMALOG 96 66 64 214
BISOPROLOL FUMARATE 95 85 65 163
ACETAMINOPHEN-CODEINE 89 40 S3 66 124
LIPITOR 88 54 67 77
CEPHALEXIN 86 52 68 119
SPIRONOLACTONE 83 66 69 85
MEGESTROL ACETATE 83 67 R 69 92
NOVOLOG 82 70 71 178
VERAPAMIL ER 82 79 71 87
CYCLOBENZAPRINE HCL 81 42 R 73 64
TRAZODONE HCL 79 45 74 40
PANTOPRAZOLE SODIUM 78 36 75 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 55 76 76
AMLODIPINE BESYLATE-BENAZEPRIL 77 55 76 41
DILTIAZEM 24HR CD 76 55 78 156
NIASPAN 76 60 78 212
FLUOXETINE HCL 75 59 80 63
INSULIN SYRINGE 74 59 81 99
CIPROFLOXACIN HCL 73 46 82 58
CARISOPRODOL 72 0 R 83 69
CARAFATE 71 38 84 261
LEVOFLOXACIN 71 50 84 107
PHENYTOIN SODIUM EXTENDED 70 36 86 111
BENZTROPINE MESYLATE 70 33 R 86 196
METOCLOPRAMIDE HCL 70 55 86 125
ALENDRONATE SODIUM 69 35 89 38
TORSEMIDE 69 61 89 159
POLYETHYLENE GLYCOL 3350 69 48 89 67
TRIAMTERENE-HCTZ 69 52 89 61
CELEBREX 67 65 93 91
DIOVAN HCT 67 46 93 48
GEMFIBROZIL 65 45 95 103
ENALAPRIL MALEATE 64 49 96 56
LEXAPRO 63 40 97 186
GLIPIZIDE XL 63 51 97 128
ADVAIR DISKUS 63 36 97 52
IPRATROPIUM BROMIDE 60 57 100 249
HYDROXYZINE PAMOATE 59 34 R 101 205
TRAMADOL HCL-ACETAMINOPHEN 59 45 101 117
SPIRIVA 57 39 103 66
DOXYCYCLINE HYCLATE 57 38 103 89
ENABLEX 57 39 103 248
KLOR-CON M10 56 55 106 165
NOVOLIN 70-30 56 56 106 199
SEROQUEL 56 36 106 167
LOVAZA 51 25 109 120
AGGRENOX 51 51 109 219
GLYBURIDE-METFORMIN HCL 51 44 R 109 115
ATENOLOL-CHLORTHALIDONE 50 38 112 147
PROMETHAZINE HCL 50 29 R 112 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.